TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $662,000 | -54.2% | 8,797 | -83.7% | 0.00% | -33.3% |
| Q1 2022 | $1,446,000 | +588.6% | 53,847 | +1606.7% | 0.01% | +500.0% |
| Q3 2021 | $210,000 | -64.2% | 3,155 | -49.0% | 0.00% | -66.7% |
| Q1 2021 | $586,000 | +181.7% | 6,190 | +262.0% | 0.00% | +50.0% |
| Q4 2020 | $208,000 | -51.5% | 1,710 | -65.1% | 0.00% | -66.7% |
| Q3 2020 | $429,000 | +51.1% | 4,905 | -23.0% | 0.01% | -14.3% |
| Q1 2020 | $284,000 | -72.9% | 6,370 | -62.1% | 0.01% | +16.7% |
| Q4 2019 | $1,048,000 | +112.6% | 16,820 | +28.3% | 0.01% | +50.0% |
| Q3 2019 | $493,000 | – | 13,112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |